<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-I55V00000GR</udiDi>
    <basicUdiDi>B-I55V00000GR</basicUdiDi>
    <tradeName>Vidermina MD PREBIOTIC ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I55V00000</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:04:10.507Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C231109K</udiDi>
    <basicUdiDi>B-I53C231109K</basicUdiDi>
    <tradeName>Vidermina MD PREBIOTIC ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C23110</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:48.805Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C231009G</udiDi>
    <basicUdiDi>B-I53C231009G</basicUdiDi>
    <tradeName>Vidermina MD CLX ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C23100</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:48.001Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C014609D</udiDi>
    <basicUdiDi>B-I53C014609D</basicUdiDi>
    <tradeName>Vidermina MD LUBRIPIU' ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C01460</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:42.639Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C014509A</udiDi>
    <basicUdiDi>B-I53C014509A</basicUdiDi>
    <tradeName>FITORMIL Vidermina MD Ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C01450</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:41.610Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I50V08610GV</udiDi>
    <basicUdiDi>B-I50V08610GV</basicUdiDi>
    <tradeName>Vidermina MD CLX ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I50V08610</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:36.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I50V06480GS</udiDi>
    <basicUdiDi>B-I50V06480GS</basicUdiDi>
    <tradeName>Vidermina MD CLX Vaginal Ovules</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I50V06480</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:36.324Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I42V02400FM</udiDi>
    <basicUdiDi>B-I42V02400FM</basicUdiDi>
    <tradeName>FITORMIL Vidermina MD Ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I42V02400</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:23.188Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I41V10540FJ</udiDi>
    <basicUdiDi>B-I41V10540FJ</basicUdiDi>
    <tradeName>Alkagin MD Ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I41V10540</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:03:22.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-HK-A067A</udiDi>
    <basicUdiDi>B-HK-A067A</basicUdiDi>
    <tradeName>Vaginal Speculum</tradeName>
    <deviceName>Disposable Vaginal Speculums</deviceName>
    <manufacturerName>Changzhou Huankang Medical Device Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000009030</manufacturerSrn>
    <authorisedRepresentativeName>SUNGO Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000247</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U089006</emdnCode>
    <emdnDescription>VAGINAL SPECULUM, SINGLE-USE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HK-A06</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T21:54:47.190Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-GRMF000019269HYALPESSWG</udiDi>
    <basicUdiDi>B-GRMF000019269HYALPESSWG</basicUdiDi>
    <tradeName>I FOR ME</tradeName>
    <deviceName>Vaginal Suppositories of Hyaluronic acid</deviceName>
    <manufacturerName>HELP INDUSTRIAL COMMERCIAL PHARMACEUTICAL &amp; HOSPITAL PRODUCTS SOCIETE ANONYME</manufacturerName>
    <manufacturerSrn>GR-MF-000019269</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Vaginal Suppositories of Hyaluronic acid</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-13T21:42:45.089Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-GRMF000019269HYALGELVC</udiDi>
    <basicUdiDi>B-GRMF000019269HYALGELVC</basicUdiDi>
    <tradeName>I for me</tradeName>
    <deviceName>Hyaluronic acid vaginal gel</deviceName>
    <manufacturerName>HELP INDUSTRIAL COMMERCIAL PHARMACEUTICAL &amp; HOSPITAL PRODUCTS SOCIETE ANONYME</manufacturerName>
    <manufacturerSrn>GR-MF-000019269</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Hyaluronic acid vaginal gel</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T21:42:41.084Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP050EL</udiDi>
    <basicUdiDi>B-FTP050EL</basicUdiDi>
    <tradeName>PRO GYNO balance HR, BA</tradeName>
    <deviceName>Lasjt Gyn Capsule Vaginali</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTP050</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:29.057Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP046_2K2</udiDi>
    <basicUdiDi>B-FTP046_2K2</basicUdiDi>
    <tradeName>RESVAGIL VAGINAL GEL 30 ml EGY</tradeName>
    <deviceName>RESVAGIL gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FTP046</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:21.755Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP046_1JY</udiDi>
    <basicUdiDi>B-FTP046_1JY</basicUdiDi>
    <tradeName>INTIMOFEMIN 10 ml RU</tradeName>
    <deviceName>RESVAGIL gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FTP046</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:20.955Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP046EV</udiDi>
    <basicUdiDi>B-FTP046EV</basicUdiDi>
    <tradeName>INTIMOFEMIN 30 ml RU</tradeName>
    <deviceName>RESVAGIL gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FTP046</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:20.155Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP043_3JM</udiDi>
    <basicUdiDi>B-FTP043_3JM</basicUdiDi>
    <tradeName>ELASTO CURE 30 ml IQ</tradeName>
    <deviceName>Juvegyn gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FTP043</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:14.547Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP043_1JH</udiDi>
    <basicUdiDi>B-FTP043_1JH</basicUdiDi>
    <tradeName>Menocomplex gel vaginale 10 ml IT</tradeName>
    <deviceName>Juvegyn gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTP043</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:13.769Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP043_027Z</udiDi>
    <basicUdiDi>B-FTP043_027Z</basicUdiDi>
    <tradeName>JUVEGYN 30 ml UAE</tradeName>
    <deviceName>Juvegyn gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FTP043</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:12.942Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FTP043EP</udiDi>
    <basicUdiDi>B-FTP043EP</basicUdiDi>
    <tradeName>Menocomplex gel vaginale 30 ml IT</tradeName>
    <deviceName>Juvegyn gel vaginale</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTP043</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-13T20:26:12.165Z</lastUpdated>
  </row>
</eudamedExport>